American Hospital Dubai, Roche partner to help cancer patientsAmerican Hospital Dubai, a leading private hospital in the Middle East, and Roche, one of the world’s largest biotechnology companies, have announced a partnership to bring to the UAE the latest and most advanced genomic profiling solution More… |
American Hospital Dubai, Roche partner to help cancer patientsAmerican Hospital Dubai, a leading private hospital in the Middle East, and Roche, one of the world’s largest biotechnology companies, have announced a partnership to bring to the UAE the latest and most advanced genomic profiling solution More… |
Roche to help UAE strengthen strategic drug stockpileThe Ministry of Health & Prevention (Mohap) has signed an agreement with Roche Pharmaceutical Company to strengthen the UAE’s strategic drug stockpile, by adding 76 categories of drugs to aid in severe cases and emergency situations. More… |
Novartis to sell $13.8bn stake in RocheDrugmaker Novartis aims to dispose of a 13.5 billion Swiss franc ($13.8 billion) stake in its local rival Roche and has already hired banks to support the selling process, a Swiss paper reported on Sunday. The world's biggest More… |
Novartis to sell $13.8bn stake in RocheDrugmaker Novartis aims to dispose of a 13.5 billion Swiss franc ($13.8 billion) stake in its local rival Roche and has already hired banks to support the selling process, a Swiss paper reported on Sunday. The world's biggest More… |
Roche Diagnostics opens new training centre in JafzaRoche Diagnostics Middle East has inaugurated its new facility in Jafza-Jebel Ali, comprising a new state-of-the-art training centre which would provide advanced training to healthcare professionals in UAE and the Middle East. More… |
Seven $1bn-plus drugs to hit market in 2016Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1 billion-plus annual sales potential, led by new treatments for liver disease and HIV, according to a Thomson Reuters analysis. The asses More… |
Drugmaker Shire to buy Baxalta for $32bnDrugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs More… |
Drugmaker Shire to buy Baxalta for $32bnDrugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs More… |
Roche Media Academy wins healthcare and services awardA Roche Media Academy initiative won the Silver Award in Healthcare and Services category at the Middle East Public Relations Association Awards (Mepra) 2015. Launched by Roche UAE last year, the Roche Media Ac More… |